Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu
Trial record 17 of 2028 for:    oxaliplatin

Dose-dense Biweekly Docetaxel, Oxaliplatin and 5-fluorouracil as First-line Treatment in Advanced Gastric Cancer (DaeMon-Plus)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02289378
Recruitment Status : Unknown
Verified November 2014 by Lan Ping, Sixth Affiliated Hospital, Sun Yat-sen University.
Recruitment status was:  Recruiting
First Posted : November 13, 2014
Last Update Posted : November 14, 2014
Information provided by (Responsible Party):
Lan Ping, Sixth Affiliated Hospital, Sun Yat-sen University

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : October 2016
Estimated Study Completion Date : October 2017